Swedish defence material maker Saab beat second-quarter operating earnings forecasts on Friday and raised its guidance on expectations of even stronger sales this year as European military spending surges.

U.S. Bancorp notched a higher profit for the latest quarter, though interest income growth was more sluggish than anticipated.

The index trades at just over 22 times analysts’ expected earnings, in aggregate. That may seem expensive, but not when considering Big Tech.

Swedish defence material maker Saab reported a bigger-than-expected rise in second-quarter operating earnings on Friday and raised its guidance to project even stronger sales this year on the back of soaring military spending.

MPLX LP provides stable, fee-based cash flows, a 7.6% yield, and growth prospects. Click here to read an analysis of MPLX stock now.

(Reuters) -JPMorgan Chase's profit fell in the second quarter, reflecting a difficult comparison to last year when the bank had recorded a one-time accounting gain.

The family office of Sandra Ortega, an heir to the Inditex SA fortune and Spain’s wealthiest woman, posted a 71% profit jump last year, driven largely by its stake in the fashion firm.

BNY's assets under custody and administration rose 13% in the quarter ended June 30 to $55.8 trillion from a year earlier. The world's largest custodian bank said the increase reflected higher market values, client inflows and the favorable impact of the weaker U.S. dollar.

Doctors widely consider vaccines to be a money pit. Research shows that most pediatricians either break even or lose money on shots. One 2017 study found that nearly a quarter of family medicine providers and 12 percent of pediatricians stopped purchasing vaccines because of prohibitive costs.